[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100473845":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":26,"responsibleParty":81,"collaborators":83,"id":87,"slug":88,"hasResults":89,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":93,"eligibilityCriteria":94,"healthyVolunteers":89,"sex":95,"minAge":96,"maxAge":7,"enrollmentInfo":97,"targetDuration":7,"studyType":100,"phases":7,"briefSummary":101,"conditions":102,"keywords":7,"overallStatus":29,"whyStopped":7,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"University Hospital Muenster","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"PROCEDURE","Critically ill patients with continuous renal replacement therapy","Due to the observational design of the study, no study-specific interventions are performed. The treatment of the patients is completely guided by the responsible ICU physicians.",[14],{"name":15,"affiliation":16,"role":17},"Alexander Zarbock, MD","University Hospital Münster","PRINCIPAL_INVESTIGATOR",[19,23],{"name":15,"role":20,"phone":21,"phoneExt":7,"email":22},"CONTACT","+49-251-8347252","zarbock@uni-muenster.de",{"name":24,"role":20,"phone":25,"phoneExt":7,"email":7},"Melanie Meersch-Dini, MD","+49-251-47255",[27,39,49,60,69],{"facility":28,"status":29,"city":30,"state":7,"zip":7,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":7},"Univ.-Klinik Innsbruck","RECRUITING","Innsbruck","Austria","AT",{"type":34,"coordinates":35},"Point",[36,37],11.39454,47.26266,{"lat":37,"lon":36},{"facility":40,"status":29,"city":41,"state":7,"zip":7,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":48,"contacts":7},"Universidade de São Paulo","São Paulo","Brazil","BR",{"type":34,"coordinates":45},[46,47],-46.63611,-23.5475,{"lat":47,"lon":46},{"facility":50,"status":29,"city":51,"state":7,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":59,"contacts":7},"Universitätsklinikum Erlangen-Nürnberg, Abteilung für Nephrologie und Hypertensiologie","Erlangen","91054","Germany","DE",{"type":34,"coordinates":56},[57,58],11.00783,49.59099,{"lat":58,"lon":57},{"facility":61,"status":29,"city":62,"state":7,"zip":63,"country":53,"countryCode":54,"cosmosGeoPoint":64,"geoPoint":68,"contacts":7},"Kliniken Maria Hilf, Klinik für Anästhesiologie und Operative Intensivmedizin","Mönchengladbach","41063",{"type":34,"coordinates":65},[66,67],6.44172,51.18539,{"lat":67,"lon":66},{"facility":5,"status":29,"city":70,"state":7,"zip":71,"country":53,"countryCode":54,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Münster","D-48149",{"type":34,"coordinates":73},[74,75],7.62571,51.96236,{"lat":75,"lon":74},[78],{"name":79,"role":20,"phone":7,"phoneExt":7,"email":80},"Zarbock","aki@uni-muenster.de",{"type":82,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[84],{"name":85,"class":86},"Baxter Healthcare Corporation","INDUSTRY","100473845","filter-lifespan-in-continuous-renal-replacement-therapy-100473845",false,"NCT05450185","Filter Lifespan in Continuous Renal Replacement Therapy","The Effect of Filter Lifespan in Continuous Renal Replacement Therapy on the Rate of New Infections in Critically Ill Patients: a Prospective, Multicenter, Observational Trial","CRRTInfO","Inclusion Criteria:\n\n* Adult patients (age ≥18 years)\n* Critically ill patients with dialysis-dependent AKI\n* Continuous renal replacement therapy (CRRT)\n* Written informed consent\n\nExclusion Criteria:\n\n* Chronic kidney disease with estimated glomerular filtration rate (eGFR)\\\u003C30ml\u002Fmin\u002F1.73m2\n* Chronic dialysis dependency\n* Kidney transplant\n* (Glomerulo-)nephritis, interstitial nephritis, vasculitis\n* Patients on immunosuppression\n* Patients with chronic inflammatory diseases (e.g. arthritis, HIV, chronic hepatitis)\n* Persons with any kind of dependency on the investigator or employed by the sponsor or investigator","ALL","18 Years",{"count":98,"type":99},600,"ESTIMATED","OBSERVATIONAL","The only supportive therapy for patients with AKI is renal replacement therapy (RRT). In the ICU setting, continuous RRT (CRRT) is mostly favored. In a post-hoc analysis of the RICH trial (regional citrate versus systemic heparin anticoagulation for CRRT in critically ill patient with AKI), it was shown that the filter life span is associated with an increased rate of new infection and that the type of anticoagulants did not directly affect infection rate. The mechanisms of this infection rate is unknown.",[103,104,105],"Critically Ill","Continuous Renal Replacement Therapy","Infections","2024-12-06",{"date":108,"type":109},"2024-12-12","ACTUAL",{"date":111,"type":109},"2023-03-02",{"date":113,"type":99},"2025-08",{"name":5,"class":6},5]